| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/10/2006 | US20060178518 3'-[(2z)-[1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hy-drazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 08/10/2006 | US20060178504 Eotaxin: eosinophil chemotactic cytokine |
| 08/10/2006 | US20060178410 Preparation of N-{2-[4-(3-phenyl-4-methoxyphenyl)aminophenyl]ethyl}-2-hydroxy-2-(3-hydroxymethyl-4-hydroxyphenyl)ethylamine, for example; for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease |
| 08/10/2006 | US20060178401 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 08/10/2006 | US20060178379 Methods of treating patients suffering from movement disorders |
| 08/10/2006 | US20060178323 Methods for the treatment of chronic pain and compositions therefor |
| 08/10/2006 | US20060178318 Use of aurora kinase inhibitors for reducing the resistance of cancer cells |
| 08/10/2006 | US20060178317 Methods of increasing endogenous erythropoietin (EPO) |
| 08/10/2006 | US20060178316 Methods of increasing endogenous erythropoietin (EPO) |
| 08/10/2006 | US20060177901 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
| 08/10/2006 | US20060177877 Methods for identifying combinations of entities as therapeutics |
| 08/10/2006 | US20060177523 Administration of a thiol-based chemoprotectant compound |
| 08/10/2006 | US20060177520 Compositions and methods for reducing cytotoxicity and inhibiting angiogenesis |
| 08/10/2006 | US20060177516 Food-supplement composition suitable for promoting iron absorption |
| 08/10/2006 | US20060177510 Dual controlled release osmotic device |
| 08/10/2006 | US20060177499 Method for the manufacture of a pharmaceutical composition in the form of tablets containing a fibrate and tablets obtained according to the method |
| 08/10/2006 | US20060177481 Methods for forming regional tissue adherent barriers and drug delivery systems |
| 08/10/2006 | US20060177444 Concomitant drug as therapeutic agent for inflammatory bowel disease |
| 08/10/2006 | US20060177443 Integrin antagonists |
| 08/10/2006 | US20060177428 Expression vector comprising nucleotide sequences coding endothelial growth factor for use in diagnosis, prevention and treatment of tumor disorders |
| 08/10/2006 | US20060177423 Composition and method for killing of tumours |
| 08/10/2006 | US20060177419 Stimulating neutrophil function to treat inflammatory bowel disease |
| 08/10/2006 | US20060177382 Delivery of antiemetics through an inhalation route |
| 08/10/2006 | US20060177374 Treatment of cancer with active vitamin D compounds in combination with radiotherapeutic agents and treatments |
| 08/10/2006 | DE102005004343A1 Behandlung von Phantomphänomenen Treatment of phantom phenomena |
| 08/10/2006 | CA2601762A1 Dosage forms providing controlled and immediate release of cholesteryl ester transfer protein inhibitors and immediate release of hmg-coa reductase inhibitors |
| 08/10/2006 | CA2596686A1 Preventive or therapeutic agent for herpesvirus-related disease |
| 08/10/2006 | CA2596428A1 Glucuronidated nebivolol_metabolites |
| 08/10/2006 | CA2595860A1 Anti-inflammatory supplement compositions and regimens to reduce cardiovascular disease risks |
| 08/09/2006 | EP1688430A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/09/2006 | EP1688412A2 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 08/09/2006 | EP1688156A2 A filtrate composition for use in dialysis via the colon |
| 08/09/2006 | EP1688149A1 Paste formulations comprising silica |
| 08/09/2006 | EP1688144A1 Ophthalmic compositions containing quinolone-antibiotics |
| 08/09/2006 | EP1688142A1 Terfenadine carboxylate and the treatment of dermal irritation |
| 08/09/2006 | EP1688036A1 Transgenic nonhuman mammal |
| 08/09/2006 | EP1687065A2 Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor |
| 08/09/2006 | EP1687030A2 Combination of a dpp iv inhibitor and an anti-obesity or appetite regulating agent |
| 08/09/2006 | EP1687015A2 Compositions for the treatment of diseases of the oral cavity and upper respiratory tract |
| 08/09/2006 | EP1686993A2 Virucidal activities of cetylpyridinium chloride |
| 08/09/2006 | EP1686982A2 Methods and compositions for the treatment of helicobacter pylori -associated diseases using endoperoxide bridge-containing compounds |
| 08/09/2006 | EP1686951A1 Combined cosmetic or therapeutic preparation |
| 08/09/2006 | EP1686949A2 Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 08/09/2006 | EP1549308B1 Protecting a patient from possible adverse effects of inhibition of the SHH- signaling pathway by suppressing testosterone |
| 08/09/2006 | EP1448179B1 Substituted bicyclo 3.3.1 nonan-2,4,9-triones as pharmaceutical active ingredients |
| 08/09/2006 | EP1441730B1 Hydrazono-malonitriles |
| 08/09/2006 | EP1386973B1 Method of inferring diplotype configuration from the genotype of individual |
| 08/09/2006 | EP1372741B1 Morpholino imaging and therapy |
| 08/09/2006 | EP1368015B1 Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment of delayed graft function |
| 08/09/2006 | EP1354032B1 Gene regulation therapy involving ferritin |
| 08/09/2006 | EP1317453B1 Isoxazoles and their use as inhibitors of erk |
| 08/09/2006 | EP1307481B1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 08/09/2006 | EP1267954B1 Medical devices suitable for gene therapy regimens |
| 08/09/2006 | EP1263423B1 Composition for the prevention and/or treatment of vascular diseases, consisting of propionyl l-carnitine and coenzyme q10 |
| 08/09/2006 | EP1246623B1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof |
| 08/09/2006 | EP1227859B1 Neurophilin ligands for treating ocular conditions |
| 08/09/2006 | EP1171157B1 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
| 08/09/2006 | EP1144003B1 Methods and devices for delivery of agents to breast milk ducts |
| 08/09/2006 | EP1143981B1 Use of n-glycolneuraminic acid and its derivatives for the manufacture of a medicament for the treatment of hiv infections |
| 08/09/2006 | EP1044014B1 Agent for treating allergic or hypersensitivity condition |
| 08/09/2006 | EP1033979B1 Combination of cyp2a enzyme inhibitors and nicotine and their therapeutic use |
| 08/09/2006 | EP1012177B1 Estrogen receptor |
| 08/09/2006 | EP1007092B1 A process for inhibiting complement activation via the alternative pathway |
| 08/09/2006 | EP0972075B1 Methods for assessing cardiovascular status and compositions for use thereof |
| 08/09/2006 | CN1816533A Pharmaceutical composition comprising valsartan |
| 08/09/2006 | CN1816524A Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 08/09/2006 | CN1816353A Medicinal composition for preventing or treating Th1 type immunological disease |
| 08/09/2006 | CN1816345A Preventive and/or remedy for diseases accompanied by tissue destruction |
| 08/09/2006 | CN1816342A Mouth and/or throat wash |
| 08/09/2006 | CN1816340A Use of compositions comprising an estrogenic component for the treatment and prevention of musculoskeletal pain |
| 08/09/2006 | CN1816329A Combination comprising S-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]2-methylpropanethioate and an HMG COA reductase inhibitor |
| 08/09/2006 | CN1816324A Parathyroid hormone (pth) containing pharmaceutical compositions for oral use |
| 08/09/2006 | CN1814292A Anti-cancer prodrug, preparing method and use |
| 08/09/2006 | CN1814291A Medicine composition for preventing and treating degestive ulcer |
| 08/09/2006 | CN1814290A Multi-layer tablet containing calsium-path receptor retarder and ACE inhibitor, and preparing method |
| 08/09/2006 | CN1814289A Medicine composition for treating degestive ulcer |
| 08/09/2006 | CN1814288A Multi-element composition for eliminating pylorus spiro-bacillus |
| 08/09/2006 | CN1814283A Medicine composition for treating degestive ulcer |
| 08/09/2006 | CN1813987A Immunoreaction regulator of eliminating skin and mucous membrane irritability |
| 08/09/2006 | CN1813745A 5-HT 1a receptor subtype agonists |
| 08/09/2006 | CN1813707A Medicinal composition containing isosorbide mononitrate for treating hypertension |
| 08/09/2006 | CN1813706A Use of elastic protease inhibitor for preparing medicine for protecting cerebral hemorrhage |
| 08/09/2006 | CN1813699A Medicinal composition |
| 08/09/2006 | CN1813682A Method for preparing fat-soluble medicine nano micro particle |
| 08/09/2006 | CN1268645C Therapeutic compounds comprised of anti-FC receptor binding agents |
| 08/09/2006 | CN1268625C Cyclic amp-specific phosphodiesterase inhibitors |
| 08/09/2006 | CN1268618C 1,5-benzothiazepines compounds and its use as antilipemic agent |
| 08/09/2006 | CN1268600C Method for the nitration of phenolic compounds |
| 08/09/2006 | CN1268395C Remedies for chronic kidney diseases |
| 08/09/2006 | CN1268347C Metal compounds, mixed or sulphated as phosphate binders |
| 08/09/2006 | CN1268345C Method of treating hepatitis delta viral infection |
| 08/09/2006 | CN1268334C Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 08/09/2006 | CN1268331C Use of inhibitors of renin-angiotensin systemin prevention of cardiovascular events |
| 08/09/2006 | CN1268329C Use of substances that act as cascade inhibitors of the Raf/MEK/ERK signal cascade, for producing a medicament to treat DNA and RNA viruses |
| 08/08/2006 | US7087743 Bleaching; skin disorders; genetic engineered nucleic acid; topical applying |
| 08/08/2006 | US7087724 Carrier molecules |
| 08/08/2006 | US7087721 Compositions, kits and treating methods for alteration cell-cell adhesion, transport, or permeation properties of tissues |
| 08/08/2006 | US7087716 Regulator of G protein signalling |
| 08/08/2006 | US7087644 Cardiovascular disorders; stimulant of guanylate cyclase ; therapy for liver fibrosis |
| 08/08/2006 | US7087642 Inhibitors of IMPDH enzyme |